Some new research just published shows that "Pharmacological...

Some new research just published shows that "Pharmacological blockade of STING may be a promising target in the treatment of initiation of neuropathic pain."

This is the same pathway that Veyonda has been proven to inhibit. Apart from being another potential indication for Veyonda in pain management, could this be contributing to the pain reduction effects we keep seing? There was a significant reduction in pain for the majority of DARRT-1 patients, including some patients that were completely pain-free at 24 weeks.

Veyonda is the only STING blocking drug in the clinic.

https://pubmed.ncbi.nlm.nih.gov/34727296/